Aliases & Classifications for Facial Paralysis

About this section

Aliases & Descriptions for Facial Paralysis:

Name: Facial Paralysis 11 39 13 68
Facial Palsy 11 27 13
 
Bell Palsy 68

Classifications:



External Ids:

Disease Ontology11 DOID:13934
ICD1030 G51.0
MeSH39 D005158
NCIt45 C26769

Summaries for Facial Paralysis

About this section
MalaCards based summary: Facial Paralysis, also known as facial palsy, is related to recurrent peripheral facial palsy and congenital hereditary facial paralysis-variable hearing loss syndrome, and has symptoms including hemiplegia, ophthalmoplegia and oral manifestations. An important gene associated with Facial Paralysis is LIPN (Lipase Family Member N), and among its related pathways is N-cadherin signaling events. The drugs scopolamine hydrobromide and scopolamine have been mentioned in the context of this disorder. Affiliated tissues include bone, eye and skin, and related mouse phenotypes are craniofacial and respiratory system.

Related Diseases for Facial Paralysis

About this section

Diseases related to Facial Paralysis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 122)
idRelated DiseaseScoreTop Affiliating Genes
1recurrent peripheral facial palsy12.0
2congenital hereditary facial paralysis-variable hearing loss syndrome11.9
3facial palsy, familial recurrent peripheral11.9
4deafness, conductive stapedial, with ear malformation and facial palsy11.9
5bell's palsy11.9
6anotia facial palsy cardiac defect11.8
7melkersson-rosenthal syndrome11.2
8moebius syndrome11.1
9facial paresis, hereditary congenital, 110.8
10camurati-engelmann disease10.8
11familial amyloidosis, finnish type10.8
12pontine tegmental cap dysplasia10.6
13geniculate herpes zoster10.6
14cervix uteri carcinoma in situ10.2GSN, TGFB1
15thrombophlebitis migrans10.2CD40LG, TGFB1
16trichuriasis10.2CD40LG, HOXB1, LIPN
17fibrogenesis imperfecta ossium10.2LRP5, TGFB1
18cerebral lipidosis10.2CD40LG, TGFB1
19vulvar sarcoma10.1CD40LG, TGFB1
20extraosseous ewings sarcoma-primitive neuroepithelial tumor10.1LIPN, LRP5
21otitis media10.1
22malignant neoplasm of short bones of lower limb10.0CADM1, LIPN, MTRNR2L5
23bone fracture10.0
24spinal canal and spinal cord meningioma10.0CD40LG, KANTR
25facial nerve neoplasm10.0CD40LG, KANTR
26lipodystrophy, familial partial, type 610.0LRP5, TGFB1
27spastic ataxia 7, autosomal dominant10.0CD40LG, KANTR
28homocystinuria10.0CD40LG, KANTR
29spotted fever10.0CD40LG, KANTR
30anal canal adenocarcinoma10.0CD40LG, KANTR
31subglottic angioma10.0KANTR, NF2
32oropharyngeal anthrax10.0CD40LG, KANTR
33seminoma9.9KANTR, NF2
34acoustic neuroma9.9
35ectropion9.9
36neuroma9.9
37herpes simplex9.9
38generalized dystonia9.9CD40LG, KANTR
39parotitis9.9
40cholesteatoma9.9
41lymphoma9.8
42ptosis9.8
43mastoiditis9.8
44lagophthalmos9.8
45total third-nerve palsy9.8CADM1, KANTR, MTRNR2L5
46nerve fibre bundle defect9.8KANTR, LIPN, MARVELD1
47hidrocystoma9.8CD40LG, KANTR
48amyloidosis9.8
49meningitis9.8
50neuroblastoma9.7

Comorbidity relations with Facial Paralysis via Phenotypic Disease Network (PDN):


Acute CystitisEpilepsy, Focal, with Speech Disorder and with or Without Mental Retardation
Exposure KeratitisHypertension, Essential
Ischemic Heart DiseaseMechanical Ectropion
Paralytic LagophthalmosSwallowing Disorders
Transient Cerebral IschemiaGeniculate Herpes Zoster
Parotid Gland Cancer

Graphical network of the top 20 diseases related to Facial Paralysis:



Diseases related to facial paralysis

Symptoms & Phenotypes for Facial Paralysis

About this section

UMLS symptoms related to Facial Paralysis:


hemiplegia, ophthalmoplegia, oral manifestations, sciatica, facial paresis, facial palsy, upper motor neuron, facial palsy, lower motor neuron, hemifacial paralysis, back pain, headache, flaccid muscle tone, pain, seizures, syncope, tremor, chronic pain, muscle weakness, vertigo/dizziness, generalized muscle weakness, sleeplessness

MGI Mouse Phenotypes related to Facial Paralysis according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053829.0ANKH, HOXA2, HOXB1, LRP5, NF2, TGFB1
2MP:00053889.0ANKH, GSN, HOXA2, HOXB1, NF2, TGFB1
3MP:00053798.8CADM1, CD40LG, GSN, HOXB1, LRP5, NF2
4MP:00036318.4CADM1, CD40LG, GSN, HOXA2, HOXB1, LRP5
5MP:00053848.4ANKH, CADM1, CD40LG, GSN, HOXA2, HOXB1
6MP:00053878.3ANKH, CADM1, CD40LG, GSN, HOXB1, LRP5
7MP:00053907.5ANKH, CD40LG, GSN, HOXA2, HOXB1, LRP5

Drugs & Therapeutics for Facial Paralysis

About this section

Drugs for Facial Paralysis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 70)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Prednisoloneapproved, vet_approvedPhase 4, Phase 3119350-24-85755
Synonyms:
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bio-0666
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
CO-Hydeltra
CPD000718761
Co-Hydeltra
Codelcortone
Cordrol
Cortalone
Cotogesic
Cotolone
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
Delta(1)-dehydrohydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Delta-Ef-Cortelan
Delta-Stab
Delta-stab
Deltacortenol
Deltacortril
Deltacortril Enteric
Deltahydrocortisone
Deltasolone
Deltisilone
Depo-Medrol
Derpo PD
Derpo Pd
Dexa-Cortidelt Hostacortin H
Dexa-Cortidelt hostacortin H
Di Adreson F
Di-Adreson F
Di-Adreson-F
Di-adreson F
DiAdresonF
Dicortol
Donisolone
Dydeltrone
EINECS 200-021-7
Eazolin D
Econopred
Econopred Plus
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
HMS1568H10
HMS2090J05
HSDB 3385
Hostacortin H
Hydeltra
Hydeltra-Tba
Hydeltrasol
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
I-Pred
Inflamase Forte
Inflamase Mild
K 1557
Key-Pred
Klismacort
LMST02030179
LS-7669
Lentosone
Lite Pred
M-Predrol
 
MLS001304083
MLS002154250
MLS002207037
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone Acetate
Meti-Derm
Meticortelone
Metreton
MolPort-002-507-147
NCGC00179649-01
NSC 9120
NSC9120
NSC9900
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
Ocu-Pred
Ocu-Pred Forte
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
PRDL
PRED-G
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Predni-Dome
Prednicen
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
Prednisolone (JP15/USP/INN)
Prednisolone (anhydrous)
Prednisolone Acetate
Prednisolone Sodium Phosphate
Prednisolone Tebutate
Prednisolone [INN:BAN:JAN]
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Prestwick_404
Rolisone
S1737_Selleck
SAM002264639
SMR000718761
SPBio_002367
Scherisolon
Solone
Steran
Sterane
Sterolone
Supercortisol
UNII-9PHQ9Y1OLM
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-Hydrogen
Ultracortene-hydrogen
ZINC03833821
component of Ataraxoid
component of K-Predne-Dome
delta(1)-Cortisol
delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
delta-dehydrocortisol
delta-dehydrohydrocortisone
delta-hydrocortisone
prednisolone
2
Methylprednisoloneapproved, vet_approvedPhase 4, Phase 3119383-43-26741
Synonyms:
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6alpha-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6-Methylprednisolone
6-alpha-Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
AC1L1N7A
Artisone-Wyeth
Artisone-wyeth
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
Besonia
Bio-0658
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
Depo-Medrol (acetate)
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
LMST02030178
LS-118498
Lemod
M0639_SIGMA
M1665
MEPRDL
MLS000028541
MLS001148159
MLS002207191
Medesone
Medixon
Medlone 21
 
Medrate
Medrol
Medrol (TN)
Medrol Adt Pak
Medrol Dosepak
Medrol adt pak
Medrol dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [DCIT]
Metilprednisolone [Dcit]
Metipred
Metrisone
Metrocort
Metysolon
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
NSC-19987
NSC19987
Nirypan
Noretona
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Prestwick_622
Promacortine
Reactenol
S1733_Selleck
SAM002589984
SMR000058330
SPBio_002377
Sieropresol
Solomet
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
delta(1)-6alpha-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
methylprednisolone
methylprenisolone
3
AcetylcholineapprovedPhase 4, Phase 280551-84-3187
Synonyms:
ACh
Acetyl choline ion
Acetylcholine Chloride
Acetylcholine cation
 
Acetylcholinium: acetyl-Choline
Choline acetate
Choline acetate (ester)
O-Acetylcholine
acetylcholine chloride
4
Lidocaineapproved, vet_approvedPhase 41317137-58-63676
Synonyms:
.alpha.-(Diethylamino)-2,6-acetoxylidide
.alpha.-Diethylamino-2,6-dimethylacetanilide
.alpha.-Diethylaminoaceto-2,6-xylidide
.omega.-Diethylamino-2,6-dimethylacetanilide
137-58-6
2-(Diethylamino)-2',6'-acetoxylidide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide
2-Diethylamino-N-(2,6-dimethylphenyl)acetamide
4-12-00-02538 (Beilstein Handbook Reference)
6108-05-0 (MONOHYDROCHLORIDE MONOHYDRATE))
6108-05-0 (mono-hydrochloride, mono-hydrate)
73-78-9 (mono-hydrochloride)
AB00053581
AC-10282
AC1L1GGQ
AC1Q2Z7J
AKOS001026768
ARONIS23855
After Burn Double Strength Gel
After Burn Double Strength Spray
After Burn Gel
After Burn Spray
Alphacaine
Anestacon
Anestacon Jelly
BIDD:GT0342
BPBio1_000197
BRD-K52662033-001-02-6
BRD-K52662033-003-05-5
BRN 2215784
BSPBio_000179
BSPBio_001359
BSPBio_003004
Bio-0767
Bio1_000379
Bio1_000868
Bio1_001357
Bio2_000079
Bio2_000559
C07073
C14H22N2O
CAS-73-78-9
CDS1_000283
CHEBI:6456
CHEMBL79
CID3676
CPD000058189
Cappicaine
Cito optadren
Cuivasil
D00358
DB00281
Dalcaine
Dentipatch
Dentipatch (TN)
DermaFlex
Diethylaminoaceto-2,6-xylidide
Dilocaine
DivK1c_000174
DivK1c_001323
Duncaine
EINECS 205-302-8
ELA-Max
EMBOLEX
Emla
Emla Cream
Esracaine
FT-0082378
Gravocain
HMS1791D21
HMS1989D21
HMS2051C21
HMS2089E15
HMS548M19
HSDB 3350
I01-2704
IDI1_000174
IDI1_033829
Isicaina
Isicaine
Jetocaine
KBio1_000174
KBio2_000079
KBio2_001598
KBio2_002647
KBio2_004166
KBio2_005215
KBio2_006734
KBio3_000157
KBio3_000158
KBio3_002224
KBioGR_000079
KBioGR_000599
KBioSS_000079
KBioSS_001598
L-Caine
L0156
L1026_SIGMA
L7757_SIGMA
LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE)
LIDOPEN
LQZ
 
LS-805
Lanabiotic
Leostesin
Lida-Mantle
Lidocaina
Lidocaina [INN-Spanish]
Lidocaine (JP15/USP/INN)
Lidocaine (VAN)
Lidocaine Carbonate
Lidocaine Hydrocarbonate
Lidocaine Monohydrochloride
Lidocaine [USAN:INN:JAN]
Lidocainum
Lidocainum [INN-Latin]
Lidocaton
Lidoderm
Lidoject-1
Lidoject-2
Lignocaine
Lignocainum
Lingocaine
Lopac-L-5647
Lopac0_000669
MLS000069724
MLS000758263
MLS001074177
Maricaine
Maybridge1_002571
MolPort-001-783-478
N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide
N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide
NCGC00015611-01
NCGC00015611-02
NCGC00015611-03
NCGC00015611-04
NCGC00015611-14
NCGC00022176-05
NCGC00022176-06
NCGC00022176-07
NCGC00022176-08
NCGC00022176-09
NINDS_000174
NSC 40030
NSC40030
Norwood Sunburn Spray
Octocaine
Octocaine-100
Octocaine-50
Prestwick0_000050
Prestwick1_000050
Prestwick2_000050
Prestwick3_000050
Remicaine
Rocephin Kit
Rucaina
S1357_Selleck
SAM001247018
SMR000058189
SPBio_001525
SPBio_002100
STK552033
Solarcaine
Solarcaine aloe extra burn relief cream
Solcain
Spectrum2_001343
Spectrum3_001392
Spectrum4_000070
Spectrum5_001549
Spectrum_001118
UNII-98PI200987
WLN: 2N2 & 1VMR B1 F1
Xilina
Xilocaina
Xilocaina [Italian]
Xllina
Xycaine
Xylestesin
Xylesthesin
Xylocain
Xylocaine
Xylocaine (TN)
Xylocaine 5% Spinal
Xylocaine CO2
Xylocaine Dental Ointment
Xylocaine Endotracheal
Xylocaine Test Dose
Xylocaine Viscous
Xylocaine-MPF
Xylocaine-MPF with Glucose
Xylocaine-Mpf
Xylocaine-Mpf with Glucose
Xylocard
Xylocitin
Xyloneural (free base)
Xylotox
Zilactin-L
Zingo
alfa-Dietilamino-2,6-dimetilacetanilide
alfa-Dietilamino-2,6-dimetilacetanilide [Italian]
alpha-Diethylamino-2,6-dimethylacetanilide
alpha-diethylamino-2,6-dimethylacetanilide
lidocaine
nchembio.65-comp16
α-diethylamino-2,6-dimethylacetanilide
5Peripheral Nervous System AgentsPhase 4, Phase 3, Phase 223689
6Methylprednisolone HemisuccinatePhase 4, Phase 31193
7Neuroprotective AgentsPhase 4, Phase 31716
8Prednisolone hemisuccinatePhase 4, Phase 31193
9Protective AgentsPhase 4, Phase 37443
10Prednisolone phosphatePhase 4, Phase 31193
11Prednisolone acetatePhase 4, Phase 31193
12Methylprednisolone acetatePhase 4, Phase 31193
13Autonomic AgentsPhase 4, Phase 310150
14Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 313168
15Antineoplastic Agents, HormonalPhase 4, Phase 35592
16Anti-Inflammatory AgentsPhase 4, Phase 310729
17AntiemeticsPhase 4, Phase 34022
18Gastrointestinal AgentsPhase 4, Phase 38402
19glucocorticoidsPhase 4, Phase 35103
20HormonesPhase 4, Phase 314415
21Hormone AntagonistsPhase 4, Phase 313180
22VaccinesPhase 4, Phase 36611
23Neurotransmitter AgentsPhase 4, Phase 3, Phase 2, Phase 118340
24onabotulinumtoxinAPhase 4, Phase 2652
25Central Nervous System DepressantsPhase 413403
26Neuromuscular AgentsPhase 4, Phase 21180
27AcyclovirPhase 4183
28AnestheticsPhase 49596
29Anesthetics, LocalPhase 43492
30valacyclovirPhase 4106
31Anti-Infective AgentsPhase 4, Phase 322062
32incobotulinumtoxinAPhase 4, Phase 2662
33abobotulinumtoxinAPhase 4, Phase 2652
34Antiviral AgentsPhase 49967
35Cholinergic AgentsPhase 4, Phase 23992
36Botulinum ToxinsPhase 4, Phase 2697
37Botulinum Toxins, Type APhase 4, Phase 2657
38Sodium Channel BlockersPhase 41593
39Anti-Arrhythmia AgentsPhase 43093
40Diuretics, Potassium SparingPhase 41917
41
TenecteplaseapprovedPhase 3, Phase 240191588-94-0
Synonyms:
191588-94-0
D06070
Tenecteplase
Tenecteplase (USAN/INN)
 
Tissue-type plasminogen activator precursor
Tnkase
Tnkase (TN)
t- PA
t-plasminogen activator
tPA
42
Aspirinapproved, vet_approvedPhase 3115250-78-22244
Synonyms:
11126-35-5
11126-37-7
1oxr
2-(Acetyloxy)benzoate
2-(Acetyloxy)benzoic acid
2-Acetoxybenzenecarboxylic acid
2-Acetoxybenzoate
2-Acetoxybenzoic acid
2-Carboxyphenyl acetate
2349-94-2
26914-13-6
50-78-2
8-hour Bayer
98201-60-6
A 5376
A.S.A
A.S.A.
A.S.A. Empirin
A.S.A. empirin
A2093_SIGMA
A3160_SIGMA
A5376_SIGMA
A6810_SIGMA
AB1003266
AC 5230
AC1L1D8U
AC1Q1LA0
ACETYLSALICYLIC ACID
AI3-02956
AIN
AKOS000118884
ASA
Acenterine
Acesal
Acetal
Acetard
Aceticyl
Acetilsalicilico
Acetilum acidulatum
Acetisal
Acetol
Acetonyl
Acetophen
Acetosal
Acetosalic acid
Acetosalin
Acetoxybenzoic acid
Acetylin
Acetylsal
Acetylsalicylate
Acetylsalicylic acid
Acetylsalicylsaeure
Acetylsalicylsaure
Acetylsalicylsäure
Acetylsalycilic acid
Acetyonyl
Acetysal
Acetysalicylic acid
Acide acetylsalicylique
Acido O-acetil-benzoico
Acido acetilsalicilico
Acidum acetylsalicylicum
Acimetten
Acisal
Acylpyrin
Adiro
Aloxiprimum
Asacard
Asagran
Asatard
Ascoden-30
Aspalon
Aspec
Aspergum
Aspir-Mox
Aspirdrops
Aspirin
Aspirin (JP15/USP)
Aspirin [BAN:JAN]
Aspirina 03
Aspirine
Asprin
Aspro
Aspro Clear
Asteric
Azetylsalizylsaeure
Azetylsalizylsäure
BIDD:GT0118
BRN 0779271
Bay-e-4465
Bayer
Bayer Aspirin 8 Hour
Bayer Buffered
Bayer Extra Strength Aspirin For Migraine Pain
Bayer Plus
Benaspir
Bi-prin
Bialpirina
Bialpirinia
Bufferin
C01405
CCRIS 3243
CHEBI:15365
CHEMBL25
CID2244
Caprin
Cardioaspirin
Cardioaspirina
Cemirit
Claradin
Clariprin
Colfarit
Contrheuma retard
Coricidin
Crystar
D00109
D001241
DB00945
Decaten
Delgesic
Dispril
DivK1c_000555
Dolean pH 8
Duramax
ECM
EINECS 200-064-1
EU-0100038
Easprin
Easprin (TN)
Ecolen
Ecotrin
Empirin
Empirin with Codeine
Endosprin
Endydol
Entericin
Enterophen
 
Enterosarein
Enterosarine
Entrophen
Extren
Globentyl
Globoid
HMS1920E13
HMS2090G03
HMS2091K13
HMS501L17
HSDB 652
Helicon
I14-7505
IDI1_000555
Idragin
Istopirin
KBio1_000555
KBio2_001725
KBio2_002271
KBio2_004293
KBio2_004839
KBio2_006861
KBio2_007407
KBio3_002149
KBio3_002751
KBioGR_000398
KBioGR_002271
KBioSS_001725
KBioSS_002272
Kapsazal
Kyselina 2-acetoxybenzoova
Kyselina acetylsalicylova
LS-143
Levius
Lopac-A-5376
Lopac0_000038
MLS001055329
MLS001066332
MLS001336045
MLS001336046
Magnecyl
Measurin
Medisyl
Micristin
MolPort-000-871-622
NCGC00015067-01
NCGC00015067-04
NCGC00015067-09
NCGC00090977-01
NCGC00090977-02
NCGC00090977-03
NCGC00090977-04
NCGC00090977-05
NCGC00090977-06
NCGC00090977-07
NCI60_002222
NINDS_000555
NSC 27223
NSC27223
NSC406186
Neuronika
Novid
Nu-seals
Nu-seals aspirin
O-(Acetyloxy)benzoate
O-(Acetyloxy)benzoic acid
O-Acetoxybenzoate
O-Acetoxybenzoic acid
O-Acetylsalicylic acid
O-Carboxyphenyl acetate
O-accetylsalicylic acid
O-acetylsalicylic acid
PL-2200
Persistin
Pharmacin
Pirseal
Polopirin
Polopiryna
Premaspin
R16CO5Y76E [UNII]
Rheumin tabletten
Rheumintabletten
Rhodine
Rhonal
Ronal
S-211
SMR000059138
SP 189
SPBio_001838
SPECTRUM1500130
ST075414
Salacetin
Salcetogen
Saletin
Salicylic acid acetate
Salicylic acid, acetate
Salospir
Solfrin
Solprin
Solprin acid
Solpyron
Solupsan
Spectrum2_001899
Spectrum3_001295
Spectrum4_000099
Spectrum5_000740
Spectrum_001245
Spira-Dine
St. Joseph
St. Joseph Aspirin for Adults
Supac
Tasprin
Temperal
Toldex
Triaminicin
Triple-sal
UNII R16CO5Y76E
UNII-R16CO5Y76E
UNII=R16CO5Y76E
UNM-0000306102
Vanquish
WLN: QVR BOV1
XAXA
Xaxa
Yasta
ZORprin
acide 2-(acétyloxy)benzoïque
acide acétylsalicylique
aspirin
cMAP_000006
component of Midol
component of Synirin
nchem.859-comp6
o-Acetoxybenzoic acid
o-Carboxyphenyl acetate
o-acetoxybenzoic acid
o-carboxyphenyl acetate
salicylic acid acetate
ácido acetilsalicílico
43
Clopidogrelapproved, nutraceuticalPhase 3778120202-66-6, 113665-84-260606
Synonyms:
( )-(S)-Clopidogrel
(+)-(S)-Clopidogrel
(+)-Clopidogrel
(S)-Clopidogrel
(S)-Methyl 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate
113665-84-2
AC-19024
AC1L1TKZ
AC1Q41I9
BIDD:GT0284
BRD-K27721098-065-02-9
BSPBio_003211
C16H16ClNO2S
CGE
CHEBI:37941
CHEMBL1771
CID60606
CLOPIDOGREL SULFATE
CPD000550475
Clopidogrel
Clopidogrel (INN)
Clopidogrel (TN)
Clopidogrel [BAN:INN]
Clopidogrel [Ban:Inn]
Clopidogrel [INN:BAN]
Clopidogrel bisulfate
Clopidogrel bisulphate
Clopidogrel sulfate
Clopidogrelum
D07729
DB00758
DivK1c_000787
HMS2090O21
HMS502H09
HSDB 7430
IDI1_000787
 
Isocover
KBio1_000787
KBio2_000545
KBio2_003113
KBio2_005681
KBio3_002431
KBioGR_000689
KBioSS_000545
LS-172232
MLS001165708
MLS001195633
MLS001304711
Methyl (+)-(S)-alpha-(o-chlorophenyl)-6,7-dihydrothieno(3,2-c)pyridine-5(4H)-acetate
MolPort-002-885-817
MolPort-003-845-991
NCGC00163329-02
NINDS_000787
Plavix
Plavix (TN)
SAM002589956
SMR000550475
SPBio_000463
SR 25990
STK580572
STOCK5S-27782
Spectrum2_000512
Spectrum3_001606
Spectrum4_000175
Spectrum_000105
TL8000400
UNII-A74586SNO7
Zyllt
clopidogrel
clopidogrel, (+)(S)-isomer
methyl (2S)-(2-chlorophenyl)(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)ethanoate
methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate
nchem.651-comp8
44Platelet Aggregation InhibitorsPhase 32516
45Tissue Plasminogen ActivatorPhase 3, Phase 2238
46Fibrinolytic AgentsPhase 3, Phase 22388
47PlasminogenPhase 3, Phase 2242
48Purinergic P2Y Receptor AntagonistsPhase 3793
49Purinergic P2 Receptor AntagonistsPhase 3795
50Plasminogen InactivatorsPhase 310

Interventional clinical trials:

(show top 50)    (show all 66)
idNameStatusNCT IDPhase
1Scandinavian Bell's Palsy StudyCompletedNCT00510263Phase 4
2Comparison of Three Botulinum Neuromodulators for Management of Facial SynkinesisCompletedNCT03048383Phase 4
3Postmarketing Safety Study of Q/LAIV in Subjects 2 Through 49 Years of AgeCompletedNCT01985997Phase 4
4Post Marketing Surveillance Study of DysportCompletedNCT00210431Phase 4
5Reinnervation of Facial Muscles After Lengthening Temporalis MyoplastyTerminatedNCT01833221Phase 4
6Corticosteroids in Prevention of Facial Palsy After Cranial Base SurgeryCompletedNCT00438087Phase 3
7Additional 6-Month Safety Follow-up After Completion of Precursor Study 880801CompletedNCT01604746Phase 3
8A Randomized Controlled Trial of TNK-tPA Versus Standard of Care for Minor Ischemic Stroke With Proven OcclusionRecruitingNCT02398656Phase 3
9Quadrant Versus Superficial ParotidectomyWithdrawnNCT01607866Phase 2, Phase 3
10Comparison of Antibiotic Therapy Alone or Combined With Corticosteroids for the Treatment of Nontuberculous Mycobacterial Cervicofacial Lymphadenitis in Children: A Randomized Double-Blind Placebo-Controlled StudyWithdrawnNCT01614977Phase 3
11Finding of Optimal Dose for NT 201 in the Treatment of Glabellar Frown LinesCompletedNCT00430586Phase 2
12TNK-tPA Evaluation for Minor Ischemic Stroke With Proven OcclusionCompletedNCT01654445Phase 2
13Botulinum Toxin A for Emotional Stabilization in Borderline Personality Disorder (BPD)RecruitingNCT02728778Phase 2
14Treatment of Temporo-Myofascial Disorder of Muscular Origin Using Botulinum Toxin: A Prospective StudyNot yet recruitingNCT02810015Phase 2
15Metyrosine (Demser®) for the Treatment of Psychotic Disorders in Patients With Velocardiofacial SyndromeTerminatedNCT01127503Phase 2
16Study of Inhaling Carbon Monoxide to Treat Patients With Intestinal Paralysis After Colon Surgery.TerminatedNCT01050712Phase 2
17Safety Study of Inhaling Carbon Monoxide in Healthy VolunteersTerminatedNCT01050933Phase 1
18The Relationship Between Psychological Factors and Bell's PalsyUnknown statusNCT01377766
19Prednisone and Acupuncture for the Treatment of Facial Neuritis: a Multiple Center, CER in ChinaUnknown statusNCT01201642
20ePrime: Evaluation of Magnetic Resonance (MR) Imaging to Predict Neurodevelopmental Impairment in Preterm InfantsUnknown statusNCT01049594
21Effect of DBS on Quality of Life in Dyskinetic Cerebral PalsyUnknown statusNCT02097693
22Anthropometric Angular Measurement to Determine Muscle Tonus in Patients With Peripheral Facial ParalysisCompletedNCT00903669
23Microbiologic Findings of Acute Facial Palsy in ChildrenCompletedNCT01537952
24Myofunctional Therapy in Facial PalsyCompletedNCT00989209
25Steroid-Antiviral Treatment in Rehabilitation of Facial PalsyCompletedNCT02328079
26Assessment of the Cross-face Nerve Graft in the Treatment of Facial ParalysisCompletedNCT03006783
27Randomized Controlled Trial of Acupuncture to Treat Bell's Palsy According to Different StagesCompletedNCT00608660
28A Clinical Study on the Combined Magnetic and Oxygen Treatment for Bell's PalsyCompletedNCT01686464
29Acupuncture With Deqi And Psychological Effects in Treatment of Bell's PalsyCompletedNCT00685789
30Prednisone-Placebo vs Prednisone-Valacyclovir in Bell´s PalsyCompletedNCT00561106
31Study of a New Technique to Improve the Symptoms of Orofacial Discomfort in Patients With Peripheral Facial ParalysisCompletedNCT01327157
32Cognitive Function and Emotional Possessing in Bilateral Facial PalsyCompletedNCT02179450
33Complications in Parotid SurgeryCompletedNCT02486393
34Post-parotidectomy Facial Paresis: Intraoperative and Postoperative FactorsCompletedNCT02527226
35Retrospective Clinical Outcome of Parotid Tumor SurgeryCompletedNCT01983176
36Clinical Research Core Dental Screening ProtocolCompletedNCT00090818
37Ultrasound Evaluation of Tongue Movements in Speech and SwallowingCompletedNCT00001167
38Popliteal Block for Postoperative Pain in Knee-ankle Soft Tissue Surgery in Cerebral PalsyCompletedNCT02507700
39Brain Reorganization Following Constraint-Induced Therapy in Children With Cerebral PalsyCompletedNCT00100503
40Botox and Suction-Curettage for Treatment of Excessive Underarm Sweating (Axillary Hyperhidrosis)CompletedNCT01274611
41Home-Based Diagnosis and Management of Sleep-Related Breathing Disorders in Spinal Cord InjuryCompletedNCT01882257
42Tactile Learning in Stroke PatientsCompletedNCT00283881
43Natural History in CCFDN and IBM SyndromesCompletedNCT01902940
44MDs on Botox Utility (MOBILITY)CompletedNCT00535938
45Finding the Optimal Voluntary Exercise Parameters for Those Living With QuadriplegiaCompletedNCT03146728
46Morphometric Study of the Muscles of the Skin in MRI 3 Tesla in Patients With Facial Paralysis.RecruitingNCT03115203
47The Role of a Device to Evaluate the Neuromuscular Function in Assessing Muscle in Facial Paralysis PatientsRecruitingNCT02489162
48The Prehospital Selection of Acute Stroke PatientsRecruitingNCT03072524
49Quantification, Analysis and Simulation of Facial Mimics MovementsRecruitingNCT02002572
50R. I. S. POS. T. ARecruitingNCT01991665

Search NIH Clinical Center for Facial Paralysis

Inferred drug relations via UMLS68/NDF-RT46:


Cochrane evidence based reviews: facial paralysis

Genetic Tests for Facial Paralysis

About this section

Genetic tests related to Facial Paralysis:

id Genetic test Affiliating Genes
1 Facial Palsy27

Anatomical Context for Facial Paralysis

About this section

MalaCards organs/tissues related to Facial Paralysis:

36
Bone, Eye, Skin, Testes, Breast, Heart, Cortex

Publications for Facial Paralysis

About this section

Articles related to Facial Paralysis:

(show top 50)    (show all 621)
idTitleAuthorsYear
1
Comparing Patient, Casual Observer, and Expert Perception of Permanent Unilateral Facial Paralysis. (28056121)
2017
2
Association of Facial Paralysis-Related Disability With Patient- and Observer-Perceived Quality of Life. (27253905)
2016
3
Asymmetry of Facial Mimicry and Emotion Perception in Patients With Unilateral Facial Paralysis. (26892786)
2016
4
Emerging vs Time-Tested Methods of Facial Grading Among Patients With Facial Paralysis. (27101446)
2016
5
Bilateral Facial Paralysis as Presenting Symptoms in Acute Lymphoblastic Leukemia. (27755454)
2016
6
Evolution of Patients With Immediate Complete Facial Paralysis Secondary to Acoustic Neuroma Surgery. (26719351)
2016
7
Lengthening temporalis myoplasty versus free muscle transfer with the gracilis flap for long-standing facial paralysis: A systematic review of outcomes. (27364924)
2016
8
The effectiveness of ayurvedic oil-based nasal instillation (Nasya) medicines in the treatment of facial paralysis (Ardita): a systematic review. (27532316)
2016
9
Yamamoto New Scalp Acupuncture, Applied Kinesiology, and Breathing Exercises for Facial Paralysis in a Young Boy Caused by Lyme Disease-A Case Report. (27102135)
2016
10
Reply: Epidemiologic Overview of Synkinesis in 353 Patients with Longstanding Facial Paralysis under Treatment with Botulinum Toxin for 11 Years. (27465198)
2016
11
Refractory Granulomatosis with Polyangiitis Presenting as Facial Paralysis and Bilateral Sudden Deafness. (27144236)
2016
12
Early Nerve Grafting for Facial Paralysis After Cerebellopontine Angle Tumor Resection With Preserved Facial Nerve Continuity. (26584060)
2016
13
Corticosteroids for Bell's palsy (idiopathic facial paralysis). (27428352)
2016
14
Spontaneity of smile after facial paralysis rehabilitation when using a non-facial donor nerve. (27460946)
2016
15
Epidemiologic Overview of Synkinesis in 353 Patients with Longstanding Facial Paralysis under Treatment with Botulinum Toxin for 11 years. (27070213)
2016
16
The timing of surgical treatment of traumatic facial paralysis: a systematic review. (27387924)
2016
17
Levator lengthening technique using cartilage or fascia graft for paralytic lagophthalmos in facial paralysis. (26952126)
2016
18
Facial Paralysis Reconstruction. (26902979)
2016
19
A young woman with acute one-sided facial paralysis. (27620636)
2016
20
Association Between Facial Nerve Monitoring With Postoperative Facial Paralysis in Parotidectomy. (27310887)
2016
21
Lengthening Temporalis Myoplasty for Single-Stage Smile Reconstruction in Children with Facial Paralysis. (27400432)
2016
22
Facial Paralysis Secondary to Extensive Perineural Spread of Adenocarcinoma of the Parotid Gland Identified by PET/CT. (26825200)
2016
23
Efficient quantitative assessment of facial paralysis using iris segmentation and active contour-based key points detection with hybrid classifier. (26968938)
2016
24
Reply: Lengthening Temporalis Myoplasty for Single-Stage Smile Reconstruction in Children with Facial Paralysis. (27437732)
2016
25
Iatrogenic Phenol Injury Causing Facial Paralysis With Tympanic Membrane and Ossicular Necrosis. (26927759)
2016
26
Bulbar Paralysis and Facial Paralysis due to Metastatic Hepatocellular Carcinoma: A Case Report and Literature Review. (26825921)
2016
27
Quality of life differences in patients with right- versus left-sided facial paralysis: Universal preference of right-sided human face recognition. (27449749)
2016
28
Assessing psychological distress in patients with facial paralysis using the Hospital Anxiety and Depression Scale. (26952127)
2016
29
Neoplastic causes of nonacute facial paralysis: A review of 221 cases. (27657317)
2016
30
Nerve Transfer for Facial Paralysis Under Intravenous Sedation and Local Analgesia forA the High Surgical Risk Elderly Patient. (27060514)
2016
31
Effect of surgical intervention on middle-ear cholesteatoma with associated facial paralysis. (27989248)
2016
32
Association Among Facial Paralysis, Depression, and Quality of Life in Facial Plastic Surgery Patients. (27930763)
2016
33
Bilateral Facial Paralysis Caused by Temporal Bone Fracture: A Case Report. (27679786)
2016
34
Periocular Reconstruction in Patients with Facial Paralysis. (27040589)
2016
35
Gracilis Free Muscle Transfer in the Treatment of Pediatric Facial Paralysis. (27097141)
2016
36
Reply: Epidemiological overview of synkinesis in 353 patients with longstanding facial paralysis under treatment with botulinum toxin for 11 years. (27088841)
2016
37
Facial paralysis induced by ear inoculation of herpes simplex virus in rat. (27095741)
2016
38
Mastoiditis and facial paralysis as initial manifestations of temporal bone systemic diseases - the significance of the histopathological examination. (27151715)
2016
39
Masseteric Nerve as "Baby Sitter" Procedure in Incomplete Facial Paralysis. (27200230)
2016
40
Clinical Efficacy of Electroneurography in Acute Facial Paralysis. (27144227)
2016
41
Bilateral facial paralysis in a non-Hodgkin lymphoma during remission period: a rare but an important condition to be investigated. (27321933)
2016
42
Bilateral Facial Paralysis: A 13-Year Experience. (27307336)
2016
43
Weakness of Eye Closure with Central Facial Paralysis after Unilateral Hemispheric Stroke Predicts a Worse Outcome. (27986397)
2016
44
Restoration of eye closure in facial paralysis using implantable electromagnetic actuator. (27642163)
2016
45
Adipose-Derived Stem Cells Enhance Axonal Regeneration through Cross-Facial Nerve Grafting in a Rat Model of Facial Paralysis. (27465163)
2016
46
Quantifying Labial Strength and Function in Facial Paralysis: Effect of Targeted Lip Injection Augmentation. (26086151)
2015
47
Teofilo Folengo's facial paralysis and unknown demise. (26105509)
2015
48
Perspectives in the reconstruction of paediatric facial paralysis. (26488534)
2015
49
Post-Traumatic Bilateral Facial Paralysis Associated with Temporal Bone Fracture. (26522201)
2015
50
Unexpected rare complication of the facial paralysis in a patient with an antrochoanal polyp following canine fossa puncture. (25976190)
2015

Variations for Facial Paralysis

About this section

Expression for genes affiliated with Facial Paralysis

About this section
Search GEO for disease gene expression data for Facial Paralysis.

Pathways for genes affiliated with Facial Paralysis

About this section

Pathways related to Facial Paralysis according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.7GSN, LRP5

GO Terms for genes affiliated with Facial Paralysis

About this section

Cellular components related to Facial Paralysis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1cortical actin cytoskeletonGO:00308649.8GSN, NF2

Biological processes related to Facial Paralysis according to GeneCards Suite gene sharing:

(show all 9)
idNameGO IDScoreTop Affiliating Genes
1negative regulation of osteoblast differentiationGO:004566810.3HOXA2, LRP5
2osteoblast developmentGO:000207610.2HOXA2, LRP5
3cell-cell junction organizationGO:004521610.2NF2, TGFB1
4lens fiber cell differentiationGO:007030610.1NF2, TGFB1
5negative regulation of cell-cell adhesionGO:002240810.1NF2, TGFB1
6negative regulation of DNA replicationGO:000815610.1NF2, TGFB1
7anterior/posterior pattern specificationGO:000995210.1HOXA2, HOXB1, LRP5
8oligodendrocyte developmentGO:001400310.1GSN, TGFB1
9response to radiationGO:00093149.5LRP5, TGFB1

Sources for Facial Paralysis

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet